Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Payables (2016 - 2025)

Historic Payables for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to $14.2 million.

  • Ultralife's Payables rose 1169.47% to $14.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.2 million, marking a year-over-year increase of 1169.47%. This contributed to the annual value of $14.2 million for FY2024, which is 2491.18% up from last year.
  • As of Q3 2025, Ultralife's Payables stood at $14.2 million, which was up 1169.47% from $15.0 million recorded in Q2 2025.
  • Ultralife's 5-year Payables high stood at $19.0 million for Q1 2023, and its period low was $9.2 million during Q3 2021.
  • Its 4-year average for Payables is $13.3 million, with a median of $13.4 million in 2023.
  • Its Payables has fluctuated over the past 5 years, first crashed by 4773.21% in 2024, then surged by 5508.2% in 2025.
  • Over the past 4 years, Ultralife's Payables (Quarter) stood at $9.2 million in 2021, then increased by 23.14% to $11.3 million in 2023, then grew by 24.91% to $14.2 million in 2024, then rose by 0.03% to $14.2 million in 2025.
  • Its last three reported values are $14.2 million in Q3 2025, $15.0 million for Q2 2025, and $16.6 million during Q1 2025.